ADIAAdia Nutrition, Inc.

About Adia Nutrition, Inc. (ADIA)

Adia Nutrition, Inc. (ADIA) is a Shell Companies company headquartered in Winter Park, FL, United States whose shares trade over-the-counter on the Pink tier.

Adia Nutrition Inc. (OTC Pink: ADIA), based in Winter Park, Florida, is a publicly traded company transforming healthcare and supplementation. Its medical and supplement divisions aim to boost health and vitality through innovation and expansion. Adia Med leads with a nationwide rollout of satellite locations offering Umbilical Cord Stem Cell (UCB-SC) and exosome treatments, like AdiaVita from Adia Labs LLC, with 100 million stem cells and 3 trillion exosomes per unit. These therapies address chronic inflammation, autoimmune disorders, and orthopedic issues. Partnerships with top medical entities help expand access to regenerative medicine. Full clinics with apheresis machines will also offer Autologous Hematopoietic Stem Cell Transplantation (aHSCT) for conditions like Multiple Sclerosis and Therapeutic Plasma Exchange (TPE) for diseases like Alzheimer's. The supplement division offers premium organic products, boosted by a 2024 partnership with Cement Factory LLC., including Biolete coffee with collagen and mushrooms. Adia's revenue comes from service fees, product sales, and equity stakes, while pushing for standardized stem cell protocols with FDA-approved labs. Through this dual strategy, Adia is redefining healthcare and promoting wellness nationwide.

Products and services

Adia Nutrition Inc., based in Winter Park, Florida, is an innovative health company transforming care through its subsidiaries. Adia Labs LLC leads with two premier stem cell products, selling directly to Adia Med Clinics and independent doctors. These two premier products include AdiaVita, packed with 100 million Umbilical Cord Stem Cells (UCB-SC) and 3 trillion exosomes per unit. These target chronic inflammation, autoimmune disorders, and orthopedic conditions, delivering potent regenerative power. Adia Med clinics bring these innovations to life with full and satellite locations nationwide. Full clinics offer UCB-SC and exosome therapies, Autologous Hematopoietic Stem Cell Transplantation (aHSCT) for Multiple Sclerosis, and Therapeutic Plasma Exchange (TPE) for diseases like Alzheimer’s, using cutting-edge apheresis technology. Satellite clinics broaden access to these stem cell treatments, prioritizing patient care. Adia’s subsidiary Biolete LLC provides Biolete Coffee, a protein-rich blend with mushrooms, while Adia partners with Cement Factory LLC for premium organic supplements. With a focus on stem cell excellence and clinic-based solutions, Adia is redefining wellness.

ADIA key facts

Ticker symbol

ADIA

Market tier

Pink

Sector

Financial Services

Industry

Shell Companies

Headquarters

Winter Park, FL, United States

Country of incorporation

US

Year of incorporation

1975

Employees

2

Estimated market cap

$5.76M (as of Apr 16, 2025)

Shares outstanding

95,899,861

Reporting standard

Alternative Reporting Standard

Audit status

Audited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2024)

Adia Nutrition, Inc. leadership

• Larry Powalisz — CEO
• Rebecca Miller — CFO
• Peter Martin Hellwig — Consultant

Explore more: Shell Companies stocks · Financial Services sector · Pink stocks · OTC stocks starting with A